Eksempel: Heart Attack

Søg i kliniske forsøg efter: Paroxetine

I alt 266 resultater

NCT03504475

Afsluttet

Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers

Betingelser: Major Depressive Disorder; Obsessive-Compulsive Disorder; Panic Disorder; Social Anxiety Disorder; Generalized Anxiety Disorder
NCT03274752

Aktiv, ikke rekruttering

Paroxetine-mediated GRK2 Inhibition to Reduce Cardiac Remodeling After Acute Myocardial Infarction

Betingelser: Cardiac Remodeling; Myocardial Infarction
NCT01829919

Afsluttet

Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women

Betingelser: Postmenopausal Symptoms
NCT04311463

Afsluttet

Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants

Betingelser: Anxiety Disorders
NCT01841502

Afsluttet

Interaction Between Paroxetine and Telaprevir

Betingelser: Hepatitis C Infection; Depression
NCT02681198

Afsluttet

Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers

Betingelser: Healthy
NCT01916200

Trukket tilbage

Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients

Betingelser: Depressive Disorder
NCT01416220

Afsluttet

Lithium Versus Paroxetine in Major Depression

Betingelser: Major Depressive Disorder
NCT04757571

Rekruttering

The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients

Betingelser: Rheumatoid Arthritis
NCT00406432

Afsluttet

A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects

Betingelser: Depressive Disorder
NCT00610610

Afsluttet

Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome

Betingelser: Fibromyalgia Syndrome
NCT02852577

Afsluttet

Long Term Treatment of Panic Disorder With Clonazepam or Paroxetine

Betingelser: Panic Disorder; Agoraphobia
NCT01458626

Afsluttet

Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement

Betingelser: Major Depression
NCT00560612

Afsluttet

Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)

Betingelser: Stress Disorders, Post-Traumatic
NCT00184106

Afsluttet

RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo

Betingelser: Phobic Disorders
NCT00368303

Afsluttet

A Local Register Study For Major Depression Of Paroxetine Controlled Release

Betingelser: Depressive Disorder, Major; Major Depressive Disorder (MDD)
NCT00246441

Afsluttet

Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism

Betingelser: Social Anxiety Disorder; Social Phobia; Alcohol Use Disorder; Alcohol Abuse; Alcohol Dependence
NCT01376271

Afsluttet

Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

Betingelser: Social Phobia
NCT01159821

Afsluttet

A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers

Betingelser: Healthy
NCT03894085

Rekruttering

Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment

Betingelser: Anxiety Disorder; Obsessive-Compulsive Disorder
NCT01361308

Afsluttet

Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)

Betingelser: Postmenopausal Symptoms
NCT01101841

Afsluttet

24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms

Betingelser: Hot Flashes
NCT00516113

Afsluttet

A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria

Betingelser: Premenstrual Dysphoric Disorder; Premenstrual Syndrome
NCT00620581

Afsluttet

Luteal Phase Administration of Paroxetine for the Treatment of PMDD

Betingelser: Premenstrual Dysphoric Disorder
NCT00786188

Afsluttet

Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause

Betingelser: Hot Flashes